Cross-Cutting Recommendations

  • By 2025, all European countries should have accountable population-based registries in place to track and report on HPV vaccination, HPV screening and HPV related (and other) cancer incidence, survival and mortality data.

  • ECDC should be given the authority to oversee the implementation of an EU goal to eliminate cancers caused by HPV.

  • By 2021, the EU Cancer Mission should have clear elements within its programme that support the WHO global strategy for the elimination of cervical cancer as a public health problem and the European Cancer Organisation 2019 European Cancer Summit resolution on the elimination of cancers caused by HPV. This should include supporting research priorities such as new vaccine and screening technologies as well as care and treatment modalities. Research is also needed into the vaccination of women found to be HPV-positive at cervical cancer screening as a way of interrupting the transmission of the virus into the community.

  • EU Cancer Mission goals, such as on HPV, should be complemented by an EU Cancer Masterplan that supports achievement in respect to non-research-related matters. This might include facilitating greater use of EU structural funds to achieve EU- and WHO Europe-wide HPV vaccination, cervical cancer screening, and treatment goals for HPV-related cancers.

  • As part of the coordination role that the EU should play in assisting member states to combat cancer by 2025, a public monitoring and reporting exercise should be established in respect of EU Member State cancer plans, similar to ‘the State of Health in the EU’ exercise. This should include the monitoring of actions towards goals on HPV-related cancer elimination. Such a mechanism could be developed within the context of the European Cancer Dashboard suggested within the European Parliament Research Service Report ‘Strengthening Europe in the Fight Against Cancer’.97